Latest AI and machine learning research in pancreatic diseases for healthcare professionals.
Due to the late detection, aggressive nature, and paucity of treatment options, pancreatic adenocarcinoma (PAAD) remains one of the most lethal cancers worldwide. MicroRNAs (miRNAs) are small non-coding RNAs that function as oncogenes or tumor suppressors. These are highly stable in the blood circulation, hence increasingly recognized as promising biomarkers for early cancer detection. We hypothes...
As the third leading cause of cancer related deaths in the United States, pancreatic cancer (PaC) is a highly heterogenous malignancy that can be divided into a multitude of potential subtypes, with the main 4 consisting of aberrantly differentiated endocrine exocrine (ADEX), immunogenic, progenitor, and squamous. Each PaC subtype is characterized by their unique molecular pathways and therapeutic...
Based on the Fukuoka and Kyoto international consensus guidelines, the current clinical management of intraductal papillary mucinous neoplasm (IPMN) l...
Pancreatic cancer is one of the most deadly cancers, with early detection being critical for improving patient outcomes. This study evaluates the perf...
Magnetic resonance images (MRI) of the brain exhibit high dimensionality that pose significant challenges for computational analysis. While models pro...
Large-scale cohort studies exploring the etiology of obstructive jaundice (OJ) are scarce, with current serum-based diagnostic markers offering subopt...
Pancreatic ductal adenocarcinoma (PDAC) is a rare, aggressive cancer often diagnosed late with low survival rates, due to the lack of population-wide ...
Alcohol consumption tends to increase from childhood to adolescence, and risk factors at the individual, family, and environmental level (multilevel, ...
Acute pancreatitis (AP) is a common and potentially life-threatening gastrointestinal disease that places a substantial burden on healthcare systems w...
Social and behavioral determinants of health (SBDH) are increasingly recognized as essential for prognostication and informing targeted interventions....
A major challenge in deciphering the complex genetic landscape of Polycystic Ovary Syndrome (PCOS) lies in the limited understanding of how susceptibi...
Cancer is increasingly recognized as a metabolic disease with strong nutritional determinants. Recent advances in multi-omics technologies and artific...
Pancreatic cystic lesions (PCLs) are often discovered incidentally on imaging and may progress to pancreatic ductal adenocarcinoma (PDAC). PCLs have a...
Acute pancreatitis (AP) is a common gastrointestinal disease with rising global incidence. While most cases are mild, severe AP (SAP) carries high mor...
Despite continued advances in oncology, cancer remains a leading cause of global mortality, highlighting the need for diagnostic and prognostic tools ...
Cancer is one of the leading lethal causes worldwide, with enormous impact on healthcare, economy and society. One of the main challenges of clinical ...
Recent studies have found that stigmatizing terms can incline physicians to pursue punitive approaches to patient care. The intensive care unit (ICU) ...
Opioid Use Disorder (OUD) continues to pose a pressing public health challenge across the United States, highlighting the critical need for early and ...
Substance use disorders (SUD) are a leading cause of psychiatric hospitalization among adolescents, yet the underlying diagnostic profiles and comorbi...
Building on evidence linking urinary glyphosate to chronic liver disease (CLD) and hepatocellular carcinoma (HCC), we developed urinary pesticide prof...